{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T16:38:02Z","timestamp":1775579882716,"version":"3.50.1"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.yebeh.2020.107289","type":"journal-article","created":{"date-parts":[[2020,7,20]],"date-time":"2020-07-20T18:38:17Z","timestamp":1595270297000},"page":"107289","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Efficacy and safety profile of intravenous levetiracetam versus phenytoin in convulsive status epilepticus and acute repetitive seizures in children"],"prefix":"10.1016","volume":"111","author":[{"given":"Gulser Esen","family":"Besli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elif","family":"Yuksel Karatoprak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u0131la","family":"Yilmaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2020.107289_bb0005","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1212\/CON.0000000000000285","article-title":"Epilepsy emergencies","volume":"22","author":"Hantus","year":"2016","journal-title":"Continuum (Minneap Minn)"},{"key":"10.1016\/j.yebeh.2020.107289_bb0010","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.seizure.2018.05.013","article-title":"Seizure cluster: definition, prevalence, consequences, and management","volume":"68","author":"Jafarpoura","year":"2018","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2020.107289_bb0015","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12028-012-9695-z","article-title":"Neurocritical Care Society Status Epilepticus Guideline Writing Committee. Guidelines for the evaluation and management of status epilepticus","volume":"17","author":"Brophy","year":"2012","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.yebeh.2020.107289_bb0020","doi-asserted-by":"crossref","first-page":"48","DOI":"10.5698\/1535-7597-16.1.48","article-title":"American Epilepsy Society Guideline evidence-based guideline: treatment of convulsive status epilepticus in children and adults. Report of the Guideline Committee of the American Epilepsy Society","volume":"16","author":"Glauser","year":"2016","journal-title":"Epilepsy Curr"},{"key":"10.1016\/j.yebeh.2020.107289_bb0025","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1528-1167.2008.01929.x","article-title":"The role of the newer antiepileptic drugs in the treatment of generalized convulsive status epilepticus","volume":"49","author":"Wheless","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2020.107289_bb0030","doi-asserted-by":"crossref","first-page":"158","DOI":"10.4103\/JPN.JPN_126_17","article-title":"IV Levetiracetam versus IV phenytoin in childhood seizures: a randomized controlled trial","volume":"13","author":"Singh","year":"2018","journal-title":"J Pediatr Neurosci"},{"key":"10.1016\/j.yebeh.2020.107289_bb0035","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1016\/S0140-6736(19)30724-X","article-title":"Levetiracetam versus phenytoin for second-line treatment of paediatric convulsive status epilepticus (EcLiPSE): a multicentre, open-label, randomised trial","volume":"393","author":"Lyttle","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.yebeh.2020.107289_bb0040","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1016\/S0140-6736(19)30722-6","article-title":"Levetiracetam versus phenytoin for second-line treatment of convulsive status epilepticus in children (ConSEPT): an open-label, multicentre, randomised controlled trial","volume":"393","author":"Dalziel","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.yebeh.2020.107289_bb0045","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMoa1905795","article-title":"Randomized trial of three anticonvulsant medications for status epilepticus","volume":"381","author":"Kapur","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.yebeh.2020.107289_bb0050","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1111\/epi.13121","article-title":"A definition and classification of status epilepticus \u2014 report of the ILAE Task Force on Classification of Status Epilepticus","volume":"56","author":"Trinka","year":"2015","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2020.107289_bb0055","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.seizure.2012.05.010","article-title":"Intravenous levetiracetam in acute repetitive seizures and status epilepticus in children: experience from a children's hospital","volume":"21","author":"McTague","year":"2012","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2020.107289_bb0060","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1111\/j.1528-1167.2006.00586.x","article-title":"Levetiracetam intravenous infusion: a randomized, placebo-controlled safety and pharmacokinetic study","volume":"47","author":"Ramael","year":"2006","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2020.107289_bb0065","author":"Erkek"},{"key":"10.1016\/j.yebeh.2020.107289_bb0070","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.ejpn.2015.02.010","article-title":"Intravenous levetiracetam in Thai children and adolescents with status epilepticus and acute repetitive seizures","volume":"19","author":"Khongkhatithum","year":"2015","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.yebeh.2020.107289_bb0075","doi-asserted-by":"crossref","first-page":"79","DOI":"10.4103\/0972-2327.167702","article-title":"Intravenous levetiracetam in critically ill children","volume":"19","author":"Incecik","year":"2016","journal-title":"Ann Indian Acad Neurol"},{"key":"10.1016\/j.yebeh.2020.107289_bb0080","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.pediatrneurol.2014.07.021","article-title":"Efficacy and safety of IV levetiracetam in children with acute repetitive seizures","volume":"51","author":"\u0130\u015fg\u00fcder","year":"2014","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.yebeh.2020.107289_bb0085","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.seizure.2017.05.001","article-title":"Intravenous levetiracetam vs phenytoin for status epilepticus and cluster seizures: a prospective, randomized study","volume":"49","author":"Gujjar","year":"2017","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2020.107289_bb0090","doi-asserted-by":"crossref","first-page":"468","DOI":"10.3988\/jcn.2019.15.4.468","article-title":"Clinical efficacy and safety of injectable levetiracetam versus phenytoin as second-line therapy in the management of generalized convulsive status epilepticus in children: an open-label randomized controlled trial","volume":"15","author":"Noureen","year":"2019","journal-title":"J Clin Neurol"},{"key":"10.1016\/j.yebeh.2020.107289_bb0095","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.4103\/jfmpc.jfmpc_750_19","article-title":"Levetiracetam versus phenytoin in children with status epilepticus","volume":"8","author":"Wani","year":"2019","journal-title":"J Family Med Prim Care"},{"key":"10.1016\/j.yebeh.2020.107289_bb0100","doi-asserted-by":"crossref","first-page":"741","DOI":"10.18203\/2349-3291.ijcp20190722","article-title":"Levetiracetam versus phenytoin for treatment of convulsive status epilepticus in pediatric population: a randomized controlled trial","volume":"6","author":"Sharma","year":"2019","journal-title":"Int J Contemp Pediatr"},{"key":"10.1016\/j.yebeh.2020.107289_bb0105","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.jocn.2014.12.013","article-title":"Levetiracetam versus phenytoin in management of status epilepticus","volume":"22","author":"Chakravarthi","year":"2015","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.yebeh.2020.107289_bb0110","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.pediatrneurol.2009.02.016","article-title":"Role of intravenous levetiracetam in acute seizure management of children","volume":"41","author":"Kirmani","year":"2009","journal-title":"Pediatr Neurol"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505020304686?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505020304686?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:37:16Z","timestamp":1761503836000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505020304686"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":22,"alternative-id":["S1525505020304686"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2020.107289","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety profile of intravenous levetiracetam versus phenytoin in convulsive status epilepticus and acute repetitive seizures in children","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2020.107289","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107289"}}